WEHI-P8
WEHI-P8 is an orally active inhibitor targeting the coronavirus papain-like protease (PLpro) . It inhibits SARS-CoV-2 PLpro with an IC50 of 12 nM and demonstrates excellent cellular activity with an EC50 of 298 nM. Additionally, WEHI-P8 has protective effects in mice against prolonged lung and brain symptoms caused by SARS-CoV-2. This compound is applicable for research on post-COVID-19 syndrome.
Product Specifications
Field of Research
Infectious Disease & Virology
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
10950050-AAT 100 Tests
IFluor® 488 Anti-human CD95 Antibody *EOS9.1*
Sign In for Pricing
View Details 
110601C2-AAT 500 Tests
APC/Cy7 Anti-mouse CD106 Antibody *429 (MVCAM.A) *
Sign In for Pricing
View Details